N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer

Clinical trial NCT07217496 · WITHDRAWN

Trial details

NCT number: NCT07217496
Sponsor: Vadim S Koshkin
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Urothelial Carcinoma Urothelial Carcinoma Locally Advanced Urothelial Carcinoma Urothelial Cancer

Start date: 2026-02-15
Primary completion: 2027-05-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.